公众号 / 文章乳腺乳腺X线

挑战性对比增强乳腺摄影引导活检:实时多模态成像实用方法与操作流程建议

Challenging Contrast-Enhanced Mammography-Guided Biopsies: Practical Approach Using Real-Time Multimodality Imaging and a Proposed Procedural Algorithm.
PubMed 文献 · AJR Am J Roentgenol · 2022-11-02

本文介绍对比增强乳腺摄影(CEM)引导活检技术,该技术于2019年推出、2020年获FDA批准,可直接取样仅见于或主要见于重组CEM图像的可疑强化灶。作者分享实施挑战性CEM引导活检的初步经验,并提出逐步操作流程以主动应对预期技术困难、提高靶向成功率。

要点

  • CEM引导活检可取样仅见于重组CEM图像的可疑强化灶,解决CEM临床实施的主要障碍。
  • 挑战性病例需采用实时多模态成像辅助,按逐步操作流程主动应对技术困难。
  • 相关临床指征与操作技术文献稀少,本文提供初步经验与流程建议。

局限性

  • 本文为初步经验总结,非系统研究,未报告样本量、成功率或并发症等数据。
  • 相关文献稀少,流程建议需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Contrast-enhanced mammography (CEM) is an emerging functional breast imaging technique that entails the acquisition of dual-energy digital mammographic images after IV administration of iodine-based contrast material. CEM-guided biopsy technology was introduced in 2019 and approved by the U.S. FDA in 2020. This technology's availability enables direct sampling of suspicious enhancement seen only on or predominantly on recombined CEM images and addresses a major obstacle to the clinical implementation of CEM technology. The literature describing clinical indications and procedural techniques of CEM-guided biopsy is scarce. This article describes our initial experience in performing challenging CEM-guided biopsies and proposes a step-by-step procedural algorithm designed to proactively address anticipated technical difficulties and thereby increase the likelihood of achieving successful targeting.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Weaver, Yang, Scoggins, et al. Challenging Contrast-Enhanced Mammography-Guided Biopsies: Practical Approach Using Real-Time Multimodality Imaging and a Proposed Procedural Algorithm. AJR Am J Roentgenol. 2022. PMID: 36321982. doi:10.2214/AJR.22.28572

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。